ADAM ASHTON: Open Payments
NPI 1609855501 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304,964 in 467 payments from 19 companies in 2025. Trend: 2023 $291,128 · 2024 $284,570 · 2025 $304,964
Speaker / faculty: $186,655Honoraria: $59,741Consulting: $25,052Travel & lodging: $24,896Food & beverage: $8,621
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 130 | $93,601 |
| Axsome Therapeutics, Inc. | 63 | $66,714 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 55 | $46,053 |
| E.R. Squibb & Sons, L.L.C. | 56 | $34,893 |
| Neurocrine BioSciences, Inc. | 34 | $26,172 |
| ABBVIE INC. | 27 | $16,204 |
| Teva Pharmaceuticals USA, Inc. | 13 | $10,137 |
| Alkermes, Inc. | 17 | $10,005 |
| Lundbeck LLC | 16 | $228 |
| Collegium Pharmaceutical, Inc. | 11 | $226 |
Products named: REXULTI, Auvelity, CAPLYTA, INGREZZA, COBENFY, Sunosi, VRAYLAR, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
